The potential of this high-throughput method has first been evidenced by the identification of the Anaplastic lymphoma kinase (ALK), Reactive oxygen species (ROS) and Platelet derived growth factor alpha (PDGFRα) mediated Non-small cell lung cancer (NSCLC) subtypes in 2007 [11] and just recently by identification of 6 kinases prognostic for the outcome of triple negative breast cancer [12]. Here, ALK is linked to non-small cell lung carcinoma.